GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

Market Cap	487.40B
Revenue (ttm)	38.95B
Net Income (ttm)	9.28B
Shares Out	169.41M
EPS (ttm)	54.76
PE Ratio	52.54
Forward PE	46.88
Dividend	32.00 (1.11%)
Ex-Dividend Date	May 30, 2025

Volume	5,395
Average Volume	9,616
Open	2,731.10
Previous Close	2,721.25
Day's Range	2,729.50 - 2,826.00
52-Week Range	1,924.30 - 3,147.45
Beta	0.04
RSI	54.58
Earnings Date	May 13, 2025

About BOM:500660

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease;...

• Industry: Pharmaceutical Preparations
• Founded: 1924
• Employees: 3,211
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500660

Financial Performance

In 2024, BOM:500660's revenue was 38.95 billion, an increase of 12.78% compared to the previous year's 34.54 billion. Earnings were 9.28 billion, an increase of 57.23%.